Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 2:26 AM ET

Healthcare Equipment and Supplies

Company Overview of Mevion Medical Systems, Inc.

Company Overview

Mevion Medical Systems, Inc., a medical technology company, engages in the development, sale, and service of proton beam radiation therapy systems for radiation treatment of cancer patients. It offers MEVION S250, a proton radiation therapy device for use in patient imaging, positioning, monitoring, motion management, and clinical workflow. The company markets its product to a range of customers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers worldwide. It has strategic partnership with RaySearch Laboratories AB to develop advanced treatment planning solutions. Mevion Medical Systems, Inc....

300 Foster Sreet

Littleton, MA 01460

United States

Founded in 2004

165 Employees





Key Executives for Mevion Medical Systems, Inc.

Chief Executive Officer, President and Director
Age: 59
Chief Financial Officer and Vice President
Age: 63
Vice President of Operations
Vice President of Regulatory Affairs & Quality Assurance and Administration
Compensation as of Fiscal Year 2015.

Mevion Medical Systems, Inc. Key Developments

Mevion to Install Three-Room Proton Therapy System in Los Angeles

Mevion Medical Systems is announcing the Los Angeles Proton Center is building a three-room MEVION S250mx Proton Therapy System. The system will include Mevion’s HYPERSCAN pencil beam scanning technology and will be installed near Los Angeles, in the city of Montebello, on the campus of Beverly Hospital. The installation will take place in phases, with the first of the three rooms treating cancer patients in late 2017. A rendering of the Los Angeles Proton Center in Montebello, Calif., where a three-room MEVION S250mx proton therapy system will begin treating patients in 2017. The MEVION S250mx is the fully scalable version of Mevion’s revolutionary proton therapy technology and is available in two, three or four room configurations. Each room is fully independent, with its own proton accelerator, providing inherent redundancy and 100% facility uptime 365 days per year. Similar Mevion systems have ramped up to full capacity in as little as three months and achieved an annualized rate of 350 patients per room, per year. That is more than 25% better than the average U.S. proton therapy center. The Los Angeles system is the third system purchase announced by Mevion in the past six weeks. In October, Mevion announced the installation of a MEVION S250 to Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, and a MEVION S250i with HYPERSCAN to the Ackerman Cancer Center in Jacksonville, Florida.

Ackerman Cancer Center to Install Second Mevion Medical Systems's S250 Proton Therapy System

Mevion Medical Systems announced that Ackerman Cancer Center (ACC) will install a second MEVION S250 Series proton therapy system. The second ACC system is a MEVION S250i with HYPERSCAN pencil beam scanning technology, which delivers high-quality Intensity Modulated Proton Therapy (IMPT) treatments with precision and robustness. Mevion's HYPERSCAN technology operates at unmatched speeds -- volumetrically scanning tumors in less than six seconds -- eliminating many of the challenges caused by patient motion that traditional pencil beam scanning solutions encounter. Its tumor targeting capability is further enhanced by its extremely low lateral penumbra.

Mevion Medical Systems, Inc. to Secure $200 Million in Financing

Mevion Medical Systems, Inc. has entered into an investment agreement to secure approximately $200 million in financing led by HOPU Investments, YuanMing Capital, with participation from Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners. Mevion will use the funds to accelerate its worldwide expansion.

Similar Private Companies By Industry

Company Name Region
CareFusion Corporation United States
ClarVista Medical, Inc. United States
United Health Care Services, Inc. United States
Verimetrix, LLC United States
Accu-Glass, LLC United States

Recent Private Companies Transactions

Private Placement
July 24, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mevion Medical Systems, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at